Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Temple U deal to cover multiple therapeutic areas
November 28, 2011
By: Gil Roth
President, Pharma & Biopharma Outsourcing Association
GVK Biosciences has entered into a drug discovery alliance with the Moulder Center for Drug Discovery Research at Temple University. As part of the multi-year integrated drug discovery collaboration, GVK Bio will be responsible for the target validation, lead identification and lead optimization of small molecules in selected therapeutic areas, including cardiovascular, metabolic, and central nervous system disorders. The MoulderCenter is a unique, fully integrated state-of-the-art drug discovery center that is used for both internal research within Temple and for external collaborations with pharmaceutical and biotech companies and other universities, according to a GVK Bio statement. As part of the collaboration, GVK Bio will apply its integrated drug discovery expertise and technologies to identify interesting small molecules against selected targets, and will be responsible for reagent generation, assay development and establishing the screening cascade leading to lead identification and optimization. Moulder Center and GVK Bio will be jointly responsible for designing the molecules for this program. The molecules will be optimized and progressed through lead optimization to a preclinical candidate. “This business model reflects the increasing trend of collaborations between academic centers of excellence and pharmaceutical companies to discover new drugs.” said Dr. Magid Abou-Gharbia, director of the Moulder Center for Drug Discovery Research and associate dean for Research in Temple’s School of Pharmacy. “We are delighted to be working with GVK BIO’s experienced research and discovery team to further leverage both teams’ talents to identify innovative drug candidates.” Manni Kantipudi, GVK Bio’s chief executive officer, remarked, “We look forward to working with the Moulder Center for Drug Discovery Research. Dr. Abou-Gharbia is a world renowned researcher with more than 26 years of research experience and we are pleased to be working with him. This collaboration with Temple University is among several academic collaborations GVK BIO has with leading research institutions.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !